Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
Pancreatic cancer has an exclusive inhibitory tumor microenvironment characterized by a dense mechanical barrier, profound infiltration of immunosuppressive cells, and a lack of penetration of effector T cells, which constitute an important cause for recurrence and metastasis, resistance to chemothe...
Main Authors: | Huiru Zhang, Longyun Ye, Xianjun Yu, Kaizhou Jin, Weiding Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.956984/full |
Similar Items
-
Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer
by: Guo Duancheng, et al.
Published: (2023-04-01) -
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2023
by: LI Tianjiao, YE Longyun, JIN Kaizhou, WU Weiding, YU Xianjun
Published: (2024-01-01) -
Innate Lymphoid Cells: Emerging Players in Pancreatic Disease
by: Saimeng Shi, et al.
Published: (2022-03-01) -
Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway
by: Fei Qinglin, et al.
Published: (2024-01-01) -
Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
by: Saimeng Shi, et al.
Published: (2023-11-01)